Cargando…
Virtual Clinical Studies to Examine the Probability Distribution of the AUC at Target Tissues Using Physiologically-Based Pharmacokinetic Modeling: Application to Analyses of the Effect of Genetic Polymorphism of Enzymes and Transporters on Irinotecan Induced Side Effects
PURPOSE: To establish a physiologically-based pharmacokinetic (PBPK) model for analyzing the factors associated with side effects of irinotecan by using a computer-based virtual clinical study (VCS) because many controversial associations between various genetic polymorphisms and side effects of iri...
Autores principales: | Toshimoto, Kota, Tomaru, Atsuko, Hosokawa, Masakiyo, Sugiyama, Yuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498655/ https://www.ncbi.nlm.nih.gov/pubmed/28397089 http://dx.doi.org/10.1007/s11095-017-2153-z |
Ejemplares similares
-
Physiologically‐based pharmacokinetic modeling for investigating the effect of simeprevir on concomitant drugs and an endogenous biomarker of OATP1B
por: Nakayama, Shinji, et al.
Publicado: (2023) -
Physiologically‐Based Pharmacokinetic Modeling Analysis for Quantitative Prediction of Renal Transporter–Mediated Interactions Between Metformin and Cimetidine
por: Nishiyama, Kotaro, et al.
Publicado: (2019) -
A probability of benefit (AUC) approach to phase II cancer trials
por: Silcocks, Paul
Publicado: (2015) -
Population Pharmacokinetic Analysis of Pazopanib in Patients and Determination of Target AUC
por: Ozbey, Agustos Cetin, et al.
Publicado: (2021) -
Application of PBPK Modeling and Virtual Clinical Study Approaches to Predict the Outcomes of CYP2D6 Genotype‐Guided Dosing of Tamoxifen
por: Nakamura, Toshimichi, et al.
Publicado: (2018)